Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Patel

Showing results (311-320 of 348) with videos related to

Pageof 35
Sort By:
Journal of Medicinal Chemistry|November 18, 2010
Discovery of 2-(6-{[(6-fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-N-hydroxypyrimidine-5-carboxamide (CHR-3996), a class I selective orally active histone deacetylase inhibitorDavid Moffat, Sanjay Patel, Francesca Day, et al.
Blood|September 29, 2023
Spatial mapping of human hematopoiesis at single-cell resolution reveals aging-associated topographic remodelingAleksandr Sarachakov, Arina Varlamova, Viktor Svekolkin, et al.
Jac-Antimicrobial Resistance|April 24, 2026
2026 Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UKAnn L Noble, Sanjay Patel, Ellie Birnie, et al.
BMJ Open|September 30, 2021
Protocol for the Stimulating β<sub>3</sub>-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial diseaseKristen J Bubb, Jason A Harmer, Meghan Finemore, et al.
Nature Reviews. Urology|April 26, 2019
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018Yair Lotan, Trinity J Bivalacqua, Tracy Downs, et al.
Molecular Metabolism|December 17, 2018
CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO miceMatthew Riopel, Melanie Vassallo, Erik Ehinger, et al.
BJU International|July 7, 2018
Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre studyAngela B Smith, Siamak Daneshmand, Sanjay Patel, et al.
Molecular Cell|September 24, 2021
PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesisJuan F Linares, Xiao Zhang, Anxo Martinez-Ordoñez, et al.
Frontiers in Oncology|September 16, 2021
Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AMLAmanda Lopez, Sanjay Patel, Julia T Geyer, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2009
The discovery of the potent aurora inhibitor MK-0457 (VX-680)David Bebbington, Hayley Binch, Jean-Damien Charrier, et al.
Pageof 35

Showing results (311-320 of 348) with videos related to

Sort By:
Pageof 35
Journal of Medicinal Chemistry|November 18, 2010
Discovery of 2-(6-{[(6-fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-N-hydroxypyrimidine-5-carboxamide (CHR-3996), a class I selective orally active histone deacetylase inhibitorDavid Moffat, Sanjay Patel, Francesca Day, et al.
Blood|September 29, 2023
Spatial mapping of human hematopoiesis at single-cell resolution reveals aging-associated topographic remodelingAleksandr Sarachakov, Arina Varlamova, Viktor Svekolkin, et al.
Jac-Antimicrobial Resistance|April 24, 2026
2026 Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UKAnn L Noble, Sanjay Patel, Ellie Birnie, et al.
BMJ Open|September 30, 2021
Protocol for the Stimulating β<sub>3</sub>-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial diseaseKristen J Bubb, Jason A Harmer, Meghan Finemore, et al.
Nature Reviews. Urology|April 26, 2019
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018Yair Lotan, Trinity J Bivalacqua, Tracy Downs, et al.
Molecular Metabolism|December 17, 2018
CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO miceMatthew Riopel, Melanie Vassallo, Erik Ehinger, et al.
BJU International|July 7, 2018
Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre studyAngela B Smith, Siamak Daneshmand, Sanjay Patel, et al.
Molecular Cell|September 24, 2021
PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesisJuan F Linares, Xiao Zhang, Anxo Martinez-Ordoñez, et al.
Frontiers in Oncology|September 16, 2021
Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AMLAmanda Lopez, Sanjay Patel, Julia T Geyer, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2009
The discovery of the potent aurora inhibitor MK-0457 (VX-680)David Bebbington, Hayley Binch, Jean-Damien Charrier, et al.
Pageof 35